Project Grant HT9425261E020
- Federal Project Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $700,000 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on August 15, 2025, with a completion date of August 14, 2027. The award supports research investigating the DPEP1-neutrophil axis in microsatellite stable colorectal cancer, contributing to the DHA's broader mission of transforming healthcare for service members and the...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Massachusetts General Hospital (MGH) a $1.35M Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025 through June 30, 2029. The award funds research investigating metabolites and metabolic pathways in relation to Crohn disease risk, with research activities conducted at MGH's Boston, Massachusetts location. This biomedical research initiative aligns with the DHA's...
- Federal Grant Award Summary The University of Connecticut Health Center received a $172,355 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2028. This award supports research investigating spatial transcriptomic and proteomic shifts in tumor-infiltrating immunocytes to advance melanoma therapeutics. The project represents a principal investigator change on a partnering award...
- Summary The Defense Health Agency (DHA) awarded a $516,256 Project Grant to VA Connecticut Research & Education Foundation, Inc. under the Military Medical Research and Development program (CFDA 12.420) for a three-year project commencing April 1, 2026 and concluding March 31, 2029. The grant funds the development of comprehensive risk stratification methodologies for hepatocellular carcinoma (HCC) in veterans with chronic hepatitis B virus (HBV) infection. This research initiative addresses...
- Federal Project Grant Award Summary Yale University received a $1.25 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2026 through June 30, 2029. The award supports research targeting KDM5 histone demethylases as a therapeutic approach to treat breast cancer. This research initiative aligns with the DHA's mission to advance biomedical innovations that transform healthcare for military service...
- Federal Project Grant Award Summary Yale University received a $1,009,054 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2029. The award supports research focused on the discovery and therapeutic targeting of endogenous retroviruses in clear cell renal cell carcinoma. This biomedical research initiative addresses cancer treatment through investigation of endogenous...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $352,000 under the Military Medical Research and Development program (CFDA 12.420) to the Sloan-Kettering Institute for Cancer Research for the project period September 1, 2025, through August 31, 2027. The award supports research focused on augmenting the in vivo efficacy of a novel lanosterol synthase inhibitor in glioblastoma treatment. This research aligns with the DHA's mission to transform healthcare for service...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $1.95 million Project Grant to the Salisbury Foundation for Research and Education (doing business as Hefner Ba Medical Center) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2029. This research initiative investigates the relationship between blast exposure and cellular senescence in veterans, addressing a critical health priority affecting military...
- Federal Project Grant Award Summary Award Overview The Defense Health Agency (DHA) awarded Dartmouth-Hitchcock Clinic a Project Grant of $5,163,060 under the Military Medical Research and Development program (CFDA 12.420) for research titled "Therapeutic Targeting of the Tumor Microenvironment in Triple-Negative Breast Cancer Patients at High Risk of Relapse and Preclinical Models of Lung Metastases." The award was issued on May 15, 2025, with a performance period extending through May...
- Federal Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $2.39 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2029. The award funds biomedical research investigating the molecular basis of post-injury syndrome and mineralization disorders, with particular focus on decoding inflammatory mechanisms underlying these conditions. This research...
The Defense Health Agency (DHA) awarded $1.1 million through the Military Medical Research and Development program (CFDA 12.420) to VA Connecticut Research & Education Foundation, Inc. for the project "From Service to Survival: Investigating the Associations Between Military Deployment and Early-Onset Colorectal Cancer Mortality in Veterans." The award, effective June 1, 2026 through May 31, 2030, funds a four-year research initiative to examine potential correlations between military deployment experiences and the incidence and mortality rates of early-onset colorectal cancer among the veteran population. This hypothesis-driven research contributes to the DHA's broader mission to transform healthcare for service members and the American public through innovative medical solutions addressing critical health challenges. The VA Connecticut Research & Education Foundation will deliver comprehensive research and development services including epidemiological analysis, data collection and management, qualitative and quantitative analysis of deployment-related health outcomes, and clinical research coordination. As a non-profit research organization specializing in federally-funded veteran healthcare studies, the foundation will conduct this multi-year investigation at its West Haven, Connecticut location, leveraging its established expertise in healthcare research partnerships and veteran health outcome initiatives. The project aligns with the Military Medical Research and Development program's emphasis on cancer research and represents a representative award within the typical $152,192 to $7.0 million funding range and two-to-four-year performance periods characteristic of this DHA program.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.1m | 3/2/26 |